Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             77 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual disease Zheng, Jing

104 3 p. 1867-1876
artikel
2 Antibiotic lock therapy for the treatment of peripherally inserted central venous catheter-related bloodstream infection in patients with hematological malignancies: a single center retrospective study Zhang, Qin

104 3 p. 1975-1984
artikel
3 Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study Castellino, Alessia

104 3 p. 1655-1667
artikel
4 A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome Garcia-Manero, Guillermo

104 3 p. 1577-1585
artikel
5 A predictive diagnostic model for refractory diffuse large B-cell lymphoma: a single-center retrospective cohort study Lin, Yun

104 3 p. 1697-1704
artikel
6 A randomized controlled trial of conventional GVHD prophylaxis with or without teprenone for the prevention of severe acute GVHD Kitamura, Wataru

104 3 p. 1917-1929
artikel
7 Assessment of anemia recovery using peripheral blood smears by deep semi-supervised learning Yan, Qianming

104 3 p. 1527-1539
artikel
8 Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmunization in transfusion-dependent patients with thalassemia: the first case-control study in Iran Kargar, Masoud

104 3 p. 1493-1499
artikel
9 Azacitidine in combination with HAG for newly diagnosed and relapsed/refractory AML: a prospective cohort study Pan, Hong

104 3 p. 1597-1604
artikel
10 Biomarkers in clonal haematopoiesis of indeterminate potential (CHIP) linking cardiovascular diseases, myeloid neoplasms and inflammation Tan, Hui Shan Valerie

104 3 p. 1355-1366
artikel
11 Building a new score system for the diagnosis and differential diagnosis of typical CLL/SLL, atypical CLL/SLL, and MCL based on the flow cytometry immunophenotyping Niyonizeye, Emile

104 3 p. 1807-1819
artikel
12 Challenges in managing iTTP: insights into ADAMTS13 inhibitor boosting during caplacizumab therapy Tanaka, Haruyuki

104 3 p. 1507-1514
artikel
13 Combined heterozygosity for hemoglobin Paksé, α-thalassemia and for hemoglobin E, β- thalassemia ̵ first appearance in Europe Schnedl, Wolfgang J.

104 3 p. 2059-2064
artikel
14 Comparative efficacy of venetoclax-based regiments in the management of chronic lymphocytic leukemia: a systematic review and metanalysis Jamil, Abdur

104 3 p. 1387-1397
artikel
15 Comparison of ATG-thymoglobulin with atg-fresenius in patients with hematological malignancies who undergo allogeneic hematopoietic stem cell transplantation: a propensity score-matched analysis Zhang, Hanyue

104 3 p. 1907-1916
artikel
16 Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2V617F variant allelic fraction in a real-world cohort Lebecque, Benjamin

104 3 p. 1587-1596
artikel
17 Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome Abdelfattah, Nesma E.

104 3 p. 1821-1832
artikel
18 Correction to: Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea Kim, Seok Jin

104 3 p. 2081
artikel
19 Correction to: Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carflzomib and antiCD38 monoclonal antibodies Costa, Luciano J.

104 3 p. 1353
artikel
20 CXCL9 and IL-18: potential biomarkers for efficacy evaluation in refractory hemophagocytic lymphohistiocytosis treated with RED (ruxolitinib, emapalumab and dexamethasone) Lan, Xuan

104 3 p. 1459-1469
artikel
21 Effect of major ABO blood group mismatched HSCT on blood transfusion and clinical outcomes in AA patients Lai, Dongdi

104 3 p. 1931-1947
artikel
22 Effect of POD24 on the prognosis of follicular and other indolent B-cell non-hodgkin lymphomas Li, Xiaoyan

104 3 p. 1427-1442
artikel
23 Efficacy and mechanism of the XPO1 inhibitor selinexor combined with decitabine in T-cell lymphoblastic lymphoma Meng, Miaomiao

104 3 p. 1747-1756
artikel
24 Efficacy of venetoclax combined with homoharringtonine and cytarabine for younger adults with newly diagnosed AML Song, Bao-Quan

104 3 p. 1617-1622
artikel
25 Epcoritamab-Induced fatal pleural effusion in diffuse large B-Cell lymphoma: a case report and literature review Takahata, Atsushi

104 3 p. 1995-2000
artikel
26 Epidemiological and clinical characteristics of children and young adults with Glanzmann’s thrombasthenia in upper Egypt: a multicenter cross-sectional study Khalifa, Gehan Lotfy Abdel Hakeem

104 3 p. 1961-1973
artikel
27 Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodies Costa, Luciano J.

104 3 p. 1329-1351
artikel
28 Exploring perceptions in the management and treatment of polycythaemia vera in the UK Bagnall, Becky

104 3 p. 1623-1631
artikel
29 Fertility assessment in long-term young female survivors with hematological disease after allogeneic hematopoietic cell transplantation: a single-center real-life cross-sectional study Hou, Yanru

104 3 p. 1897-1905
artikel
30 Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice Pellegrini, Cinzia

104 3 p. 1757-1764
artikel
31 Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival Oubari, Sara

104 3 p. 1777-1788
artikel
32 Genetic alterations and their prognostic impact in marginal zone lymphoma: a meta-analysis Li, Xijing

104 3 p. 1307-1315
artikel
33 Genetic variants in NHEJ1 and related DNA repair disorders: insights into phenotypic heterogeneity and links to hypoplastic myelodysplastic syndromes and familial hematological malignancies susceptibility Elbadry, Mahmoud I.

104 3 p. 1633-1653
artikel
34 Gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia: a regional analysis of COMMODORE in China, South-East Asia, and Russia Jiang, Bin

104 3 p. 1563-1575
artikel
35 Global, regional and national temporal trends in incidence and mortality of non-Hodgkin lymphoma from 1992 to 2021: an age-period-cohort analysis Tang, Shanshan

104 3 p. 1679-1696
artikel
36 Hematopoietic stem cell transplantation and immunosuppressive therapy: implications of clonal haematopoiesis Tan, Zhengwei

104 3 p. 1877-1886
artikel
37 Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis Jia, Yannan

104 3 p. 1857-1866
artikel
38 Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies? Karp, Simone

104 3 p. 1735-1745
artikel
39 Low levels of CD3 + and CD8 + T cells in peripheral blood can predict poor efficacy of first-line chemotherapy in patients with angioimmunoblastic T cell lymphoma Liu, Yanfei

104 3 p. 1705-1712
artikel
40 Metabolomics and machine learning approaches for diagnostic biomarkers screening in systemic light chain amyloidosis Xie, Weiwei

104 3 p. 1669-1678
artikel
41 Mixed-phenotype leukemia with TCF3::ZNF384 fusion presenting as an isolated mediastinal mass Au, Wing-Yan

104 3 p. 2023-2025
artikel
42 Molecular profiling of cell-free DNA from classic Hodgkin lymphoma patients identifies potential prognostic clusters and corresponds with disease dynamics Veltmaat, Nick

104 3 p. 1789-1800
artikel
43 Mutational heterogeneities in STAT3 and clonal hematopoiesis-related genes in acquired pure red cell aplasia Kawakami, Toru

104 3 p. 1471-1479
artikel
44 Novel AK-1 gene variants combined with thalassemia causing rare hereditary non-spherocytic hemolytic anemia in a Chinese family Chen, Lizhu

104 3 p. 2035-2043
artikel
45 Novel ETV6::RAPGEF6 fusion gene in chronic eosinophilic leukemia: compiling evidence on the role of IL3 overexpression in tumorigenesis Iberti, Mathilde

104 3 p. 2017-2021
artikel
46 Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts D’Agostino, Mattia

104 3 p. 1443-1458
artikel
47 Polatuzumab vedotin and bendamustine (Pola-B) was effective for refractory CD20-negative double-expressor lymphoma Ogasawara, Midori

104 3 p. 2075-2077
artikel
48 Post-transplant cyclophosphamide versus anti-thymocyte globulin in haploidentical stem cell transplantation: a systematic review and meta-analysis Jin, Xuelian

104 3 p. 1317-1328
artikel
49 Racial disparities in cardiovascular manifestations among patients with sickle cell trait: analysis of national inpatient sample data (2016–2020) Keesari, Praneeth Reddy

104 3 p. 1501-1506
artikel
50 Rapid detection of genetic modifiers of β-thalassemia based on MALDI-TOF MS Huang, Li

104 3 p. 1481-1492
artikel
51 Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab – case report and review of the literature Alharbi, Malak

104 3 p. 2027-2034
artikel
52 Real-world data of siltuximab for Chinese patients with iMCD: combination with BCD regimen as a potential approach for severe cases Li, Si-yuan

104 3 p. 1713-1720
artikel
53 Sequential combined bypassing therapy in haemophilia patients with high titer inhibitors: surgical experience Ding, Bingjie

104 3 p. 1949-1960
artikel
54 Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis Bode, Anna L.

104 3 p. 1551-1561
artikel
55 Significance of targeting DNMT3A mutations in AML Huang, Guiqin

104 3 p. 1399-1414
artikel
56 Successful sequential application of CAR T-cell-therapies in relapsed refractory multiple myeloma Mobascher, Paul

104 3 p. 2055-2058
artikel
57 Sustained treatment-free remission in two chronic myeloid leukemia patients after asciminib discontinuation: a report of two cases Yousefi, Arjen

104 3 p. 2065-2068
artikel
58 Targeting refractory diffuse large B cell lymphoma by CAR-WEE1 T-cells: In vitro evaluation Ahmed, Hadeer Mohamed

104 3 p. 1833-1844
artikel
59 The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia Li, Jianping

104 3 p. 1515-1525
artikel
60 The impact of obesity and its related underlying diseases on cytokine release syndrome and the efficacy of CAR-T therapy in treating B-cell malignancies Du, Mengyi

104 3 p. 1887-1895
artikel
61 The impact of various types of α-thalassemia on perinatal complications and pregnancy outcomes in pregnant women Li, Yi

104 3 p. 1541-1550
artikel
62 The mutational landscape and its longitudinal dynamics in relapsed and refractory classic Hodgkin lymphoma Witte, Hanno

104 3 p. 1721-1733
artikel
63 The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma Yan, Yuting

104 3 p. 1845-1856
artikel
64 Therapy related acute myeloid leukemia secondary to CAR-T therapy in refractory/relapsed multiple myeloma patient showing poor prognosis An, Ran

104 3 p. 2013-2016
artikel
65 The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma Koca, Oguzhan

104 3 p. 1765-1775
artikel
66 TIGIT/PVR axis regulates anti-tumor immunity in hematologic malignancies Meng, Fanqiao

104 3 p. 1415-1426
artikel
67 Tirabrutinib for CNS relapsed primary vitreoretinal lymphoma Yoshida, Nao

104 3 p. 2073-2074
artikel
68 Total psoriasis regression in a patient with chronic myeloid leukemia treated using nilotinib Horňák, Tomáš

104 3 p. 2001-2004
artikel
69 TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy Katagiri, Seiichiro

104 3 p. 1801-1806
artikel
70 t(14;22)(q32;q11) translocation involving IGH and IGL acquired at progression of splenic marginal zone lymphoma treated with rituximab, ibrutinib, and obinutuzumab Geyer, Julia T.

104 3 p. 2005-2011
artikel
71 Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis Liu, Tom

104 3 p. 1605-1616
artikel
72 Tumor microenvironment as a novel therapeutic target for lymphoid leukemias Mousavi, Shahrzad

104 3 p. 1367-1386
artikel
73 Twin pregnancy during treatment with asciminib for chronic myeloid leukemia – a case report Gutierrez de Moraes Pereira, Géssika B. G. M.

104 3 p. 2051-2054
artikel
74 Unusual peripheral T-cell lymphoma with a cytotoxic phenotype presenting in the pancreas Dubois, Juliette

104 3 p. 2045-2049
artikel
75 Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm Lee, Benjamin J.

104 3 p. 2069-2071
artikel
76 Visual presentation of age differences in relative survival of hematological neoplasms in Sweden and the neighboring countries Hemminki, Kari

104 3 p. 1985-1993
artikel
77 When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma Yiğit Kaya, Süreyya

104 3 p. 2079-2080
artikel
                             77 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland